8.76
price up icon8.42%   0.68
after-market Handel nachbörslich: 9.01 0.25 +2.85%
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
25.80%
5.418
4.307 5.814 7.737 -
Operating Income/Loss
60.00%
-13.85
-8.655 -10.33 -16.46 -14.27
Income/Loss From Continuing Operations Before Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Income/Loss From Continuing Operations After Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Net Income/Loss
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Diluted Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Basic Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Diluted Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):